Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
118
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer

Faris Abushamma1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;2 Department of Urology, An-Najah National University Hospital, Nablus, 44839, Palestine;3 Bristol Urological Institute, North Bristol NHS Trust, Bristol, UKCorrespondence[email protected]
,
Zain Khayyat1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine
,
Aya Soroghle1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine
,
Sa’ed H Zyoud4 Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, an-Najah National University, Nablus, 44839, Palestine;5 Clinical Research Center, an-Najah National University Hospital, Nablus, 44839, Palestine
,
Ahmad Jaradat1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;2 Department of Urology, An-Najah National University Hospital, Nablus, 44839, PalestineORCID Iconhttps://orcid.org/0000-0002-6537-2943
ORCID Icon,
Maha Akkawi1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;6 Department of Pathology, An-Najah National University Hospital, Nablus, 44839, Palestine
,
Hanood Aburass1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;6 Department of Pathology, An-Najah National University Hospital, Nablus, 44839, PalestineORCID Iconhttps://orcid.org/0000-0003-1949-4883
ORCID Icon,
Iyad K K Qaddumi7 Department of Urology, Rafedia General Hospital, Nablus, 44839, Palestine
,
Razan Odeh8 Department of Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine
,
Husam Salameh8 Department of Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine
&
Salah Albuheissi3 Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK
 show all
Pages 2937-2945 | Published online: 31 Mar 2021

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386. doi:10.1002/ijc.2921025220842
  • Larsson SC, Andersson SO, Johansson JE, Wolk A. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer. 2008;44(17):2655–2660. doi:10.1016/j.ejca.2008.07.01218707871
  • Comperat E, Larre S, Roupret M, et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch. 2015;466(5):589–594. doi:10.1007/s00428-015-1739-225697540
  • Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71(3):447–461. doi:10.1016/j.eururo.2016.05.04127324428
  • Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466. doi:10.1016/j.eururo.2005.12.03116442208
  • Liedberg F, Anderson H, Mansson A, Mansson W. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol. 2003;37(5):396–400. doi:10.1080/0036559031000624614594688
  • Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S; West Midlands Urological Research Group. Delay and survival in bladder cancer. BJU Int. 2002;89(9):868–878. doi:10.1046/j.1464-410X.2002.02776.x12010230
  • Mielczarek L, Zapala P, Krajewski W, et al. Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study. Cent Eur J Urol. 2020;73(2):152–159. doi:10.5173/ceju.2020.0158
  • Abushamma F, Jaradat A, Al-azab R, et al. Recommendations and algorithm to deal with urological surgeries in the Middle East during COVID-19 Pandemic: review article and regional expert opinion. Pal Med Pharm J. 2020;5(2):133–139.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Taylor J, Becher E, Steinberg GD. Update on the guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2020;125(2):197–205. doi:10.1111/bju.1491531597003
  • Ritch CR, Velasquez MC, Kwon D, et al. Use and Validation of the AUA/SUO risk grouping for nonmuscle invasive bladder cancer in a contemporary Cohort. J Urol. 2020;203(3):505–511. doi:10.1097/JU.000000000000059331609178
  • Witjes JA. Follow-up in non-muscle invasive bladder cancer: facts and future. World J Urol. 2020. doi:10.1007/s00345-020-03569-2
  • Datovo JCF, Neto WA, Mendonca GB, Andrade DL, Reis LO. Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC). World J Urol. 2019;37(10):2067–2071. doi:10.1007/s00345-019-02697-830805685
  • National Institute for Health and Care Excellence (NICE). Suspected cancer: recognition and referral; NICE guideline [NG12]; 2015. Available from: https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers. Accessed 613, 2020.
  • Sylvester RJ, Oosterlinck W, Holmang S, et al. Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pta-pt1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol. 2016;69(2):231–244. doi:10.1016/j.eururo.2015.05.05026091833
  • Sylvester RJ, van der MA, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002;168(5):1964–1970. doi:10.1016/S0022-5347(05)64273-512394686
  • Faba OR, Palou J, Breda A, Villavicencio H. High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment. World J Urol. 2012;30(6):833–840. doi:10.1007/s00345-012-0967-123070534
  • Mostafid H. Cystoscopic surveillance for bladder cancer: learning the lessons forced upon us by the Covid-19 pandemic. Scand J Urol. 2020;1–2. doi:10.1080/21681805.2020.1794956

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.